The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AUTOLUS THERAPEUTICS PLC | SPON ADS | 05280R100 | 57,925 | 3,597,796 | SH | DFND | 2 | 0 | 0 | 3,597,796 | |
AUTOLUS THERAPEUTICS PLC | SPON ADS | 05280R100 | 105,569 | 6,557,082 | SH | DFND | 1 | 0 | 0 | 6,557,082 | |
AUTOLUS THERAPEUTICS PLC | SPON ADS | 05280R100 | 23,174 | 1,439,356 | SH | DFND | 1,331,713 | 0 | 10,262,521 | ||
EVOFEM BIOSCIENCES INC | Common | 30048L104 | 22,295 | 3,357,718 | SH | DFND | 2 | 0 | 3,357,718 | 0 | |
EVOFEM BIOSCIENCES INC | Common | 30048L104 | 60,680 | 9,138,504 | SH | DFND | 1 | 0 | 9,049,170 | 89,334 | |
EVOFEM BIOSCIENCES INC | Common | 30048L104 | 8,218 | 1,237,613 | SH | DFND | 0 | 1,237,613 | 0 | ||
NUCANA PLC | SPON ADR | 67022C106 | 21,985 | 2,118,000 | SH | DFND | 1 | 0 | 2,118,000 | 0 | |
PROTHENA CORP PLC | SHS | G72800108 | 78,734 | 7,448,790 | SH | DFND | 1 | 0 | 7,448,790 | 0 | |
PROTHENA CORP PLC | SHS | G72800108 | 14,005 | 1,325,000 | SH | DFND | 0 | 1,325,000 | 0 | ||
THERAVANCE BIOPHARMA INC | Common | G8807B106 | 180,724 | 11,066,980 | SH | DFND | 1 | 0 | 11,066,980 | 0 | |
THERAVANCE BIOPHARMA INC | Common | G8807B106 | 17,849 | 1,093,000 | SH | DFND | 0 | 1,093,000 | 0 |